TY - JOUR
T1 - Covid vaccine dilemma curbing the herd immunity in India-Jab or no jab?
AU - Rai, Srinidhi
AU - Rai, Tirthal
AU - Sindhu, H.
AU - Shamantha Rai, B.
AU - Rithesh Pakkala, P.
N1 - Funding Information:
Zydus Cadila vaccine (ZyCoV-D) - a plasmid DNA vaccine manufactured by Cadila Healthcare (Zydus Cadila), Ahmedabad, India (supported by the department of Biotechnology, Government of India).
Publisher Copyright:
© 2021, Indian Association of Biomedical Scientists. All rights reserved.
PY - 2021
Y1 - 2021
N2 - After the devastating second wave of COVID-19, with the rapid increase in the number of new cases in many states of India marking the beginning of a probable third wave of COVID-19, our best bet is taking a jab to protect against COVID-19. Currently, licensed vaccines are found to be reasonably safe and effective. The second wave of COVID-19 was devastating, but it's a silver lining to note that most of the individuals who had taken the jab recovered with mild infections, and the hospitalization rates among jabbed individuals were meager. Various rumours related to the efficacy, safety, content, and side effects of the vaccine in India had caused a plunge in the vaccine acceptance rate leading to hesitancy and carelessness among the Indian population. This is a critical time for facts, not fear or rumors. This review provides an insight into the myths, pros and cons, and efficacy of the available vaccines.
AB - After the devastating second wave of COVID-19, with the rapid increase in the number of new cases in many states of India marking the beginning of a probable third wave of COVID-19, our best bet is taking a jab to protect against COVID-19. Currently, licensed vaccines are found to be reasonably safe and effective. The second wave of COVID-19 was devastating, but it's a silver lining to note that most of the individuals who had taken the jab recovered with mild infections, and the hospitalization rates among jabbed individuals were meager. Various rumours related to the efficacy, safety, content, and side effects of the vaccine in India had caused a plunge in the vaccine acceptance rate leading to hesitancy and carelessness among the Indian population. This is a critical time for facts, not fear or rumors. This review provides an insight into the myths, pros and cons, and efficacy of the available vaccines.
UR - http://www.scopus.com/inward/record.url?scp=85125565789&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125565789&partnerID=8YFLogxK
U2 - 10.51248/.V41I4.975
DO - 10.51248/.V41I4.975
M3 - Review article
AN - SCOPUS:85125565789
SN - 0970-2067
VL - 41
SP - 706
EP - 713
JO - Biomedicine
JF - Biomedicine
IS - 4
ER -
